Sutro Biopharma, Inc. SEC filings STRO

Sutro Biopharma, Inc. has 624 filings in SEC EDGAR's recent list, going back to Nov 8, 2006. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 12, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.

Form Description Filed Period
10-Q Quarterly report Aug 12, 2026 Jun 30, 2026
10-Q Quarterly report May 14, 2026 Mar 31, 2026
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
10-Q Quarterly report May 8, 2025 Mar 31, 2025
10-Q Quarterly report Nov 13, 2024 Sep 30, 2024
10-Q Quarterly report Aug 13, 2024 Jun 30, 2024
10-Q Quarterly report May 13, 2024 Mar 31, 2024
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
10-Q Quarterly report Aug 10, 2023 Jun 30, 2023
10-Q Quarterly report May 15, 2023 Mar 31, 2023
10-Q Quarterly report Nov 8, 2022 Sep 30, 2022
10-Q Quarterly report Aug 8, 2022 Jun 30, 2022
10-Q Quarterly report May 9, 2022 Mar 31, 2022
10-Q Quarterly report Nov 10, 2021 Sep 30, 2021
10-Q Quarterly report Aug 9, 2021 Jun 30, 2021
10-Q Quarterly report May 7, 2021 Mar 31, 2021
10-Q Quarterly report Nov 5, 2020 Sep 30, 2020
10-Q Quarterly report Aug 6, 2020 Jun 30, 2020
10-Q Quarterly report May 11, 2020 Mar 31, 2020
10-Q Quarterly report Nov 8, 2019 Sep 30, 2019
10-Q Quarterly report Aug 14, 2019 Jun 30, 2019
10-Q Quarterly report May 15, 2019 Mar 31, 2019
10-Q Quarterly report Nov 14, 2018 Sep 30, 2018

Showing 24 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
STRO (Nasdaq)
Fiscal year ends
December 31
Headquarters
South San Francisco, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1382101
Former names
SUTRO BIOPHARMA INC (until Nov 8, 2018); Fundamental Applied Biology Inc (until Oct 24, 2007)

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.